Related Experiment Video
Updated: Jun 18, 2025
15:27
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
20.8K
START: A Versatile Platform for Bacterial Ligand Sensing with Programmable Performances
Jeongwon Kim1, Minchae Seo1, Yelin Lim1
1Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|July 30, 2024
Summary
Researchers developed a new Synthetic Trans-Acting Riboswitch with Triggering RNA (START) platform for precise gene regulation. This innovative system offers tunable ligand sensitivity and enables complex logic gate construction for bioengineering applications.
Area of Science:
- Synthetic biology
- Molecular biology
- Bioengineering
Background:
- Gene regulation relies on transcription factors, but their complexity hinders bioengineering.
- Existing synthetic regulators face challenges in sensitivity and programmability.
Purpose of the Study:
- To introduce a novel platform, START (Synthetic Trans-Acting Riboswitch with Triggering RNA), for ligand-responsive gene regulation.
- To engineer high-performance synthetic biosensors with tunable sensitivity and dynamic range.
Main Methods:
- Inspired by bacterial riboswitches and toehold switches.
- Employed rational sequence design and domain optimization for START development.
- Integrated modularity and composability for genetic circuit construction.
Main Results:
- Achieved high-performance STARTs with up to a 67.29-fold dynamic range.
- Demonstrated tunable ligand sensitivity for precise control.
- Successfully implemented Boolean logic gates (OR, AND, NOT) for multiple ligand inputs.
Conclusions:
- The START platform provides a versatile and intuitive strategy for synthetic biosensor engineering.
- Enables flexible genetic circuit construction for diverse applications.
- Offers a novel riboregulator chassis for advancing synthetic biology and bioengineering.
